Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to ...

Penn Engineers have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy ...

Moderna will pay US$950-million upfront in July, 2026, with an additional US$1.3-billion contingent on the outcome of a ...

Hopewell Therapeutics sublicenses its proprietary lipid nanoparticles for novel cancer vaccine to Foxcroft Therapeutics: Woburn, Massachusetts Saturday, March 7, 2026, 17:00 Hrs [ ...

Vaccines and other medicines are often packed in little fat droplets, or lipids. In this form, they are absorbed by cells and release their “cargo” once they are there. The trigger is a change in the ...

Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Since then, ...

Partner Dan Shores will present a webinar titled "The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape" for Medmarc, the leading expert in the products liability risks facing medical ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...